Image Source: Unsplash
5 Biotechnology and 2 Pharmaceutical Companies on sale. Each Tuesday I cover stocks that have been requested from our channel’s YouTube subscribers. This week I covered pharmaceutical giant Merck (MRK) and the much smaller company in transition Teva Pharmaceutical (TEVA). In the biotechnology subindustry, I covered AbbVie (ABBV), Biogen (BIIB), Regeneron (REGN), Gilead (GILD), and Vertex (VRTX). Even in today’s very expensive stock market, there are many healthcare stocks that are on sale. Consequently, healthcare represents a fertile field for value-oriented investors seeking good investments that simultaneously provide a margin of safety. I believe that 6 of the 7 stocks I am covering this week fit that bill. Moreover, although one stock, Vertex, looks expensive, its price has been reverting to the mean torts fair value. As a result, patient investors might keep their eye on this stock as it gets closer and closer to attractive valuation.
Video length 00:27:29
Comments
Log in or sign up to join the conversation.